Arch Venture Fund VII LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arch Venture Fund VII LP
CIK #0001402439
EDGAR Form CIK 2011 - 2026
3 [0001402439]
4 [0001402439]
SC 13D [0001402439]
SC 13G [0001402439]
Form 13D/13G Filer Form 13D/13G Subject Filed
Arch Venture Fund VII LP 908 Devices Inc [2021-02-04]
Arch Venture Fund VII LP Twist Bioscience Corp [2019-02-14]
Arch Venture Fund VII LP Unity Biotechnology Inc [2019-02-14]
Arch Venture Fund VII LP Phaserx Inc [2016-06-06]
Arch Venture Fund VII LP Pulmatrix Inc [2015-06-25]
Arch Venture Fund VII LP Sage Therapeutics Inc [2015-02-11]
Arch Venture Fund VII LP Juno Therapeutics Inc [2015-02-11]
Arch Venture Fund VII LP Bind Therapeutics Inc [2014-02-06]
Arch Venture Fund VII LP Agios Pharmaceuticals Inc [2014-02-06]
Arch Venture Fund VII LP Bluebird Bio Inc [2014-02-06]
View All
Form 3/4/5 Subject 2011 - 2026
Arch Venture Partners X LLC
Arch Venture Partners VIII LLC
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Neumora Therapeutics Inc
Arch Venture Fund X LP
Arch Venture Fund VII LP
Arch Venture Fund VIII Overage LP
Arch Venture Partners X Overage LP
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Bybee Clinton
908 Devices Inc
Nelsen Robert
Syros Pharmaceuticals Inc
Crandell Keith
Twist Bioscience Corp
Unity Biotechnology Inc
Pulmatrix Inc
Gillis Steven
Phaserx Inc
Juno Therapeutics Inc
Sage Therapeutics Inc
Agios Pharmaceuticals Inc
Receptos Inc
Arch Venture Partners VI LP
Arch Venture Fund VI LP
Arch Venture Partners VI LLC
bluebird bio Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 703,061
Neumora Therapeutics Inc NMRA
Common Stock
2023-12-08 Other 1,176,593
Neumora Therapeutics Inc NMRA
Series B Preferred Stock · derivative
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 684,167
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 1,144,973
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 684,167
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,576,400
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
2023-09-19 Conversion 6,895,021
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Buy 1,500,000 $17.00 25,500,000
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 2,124,143
Neumora Therapeutics Inc NMRA
Common Stock
2023-09-19 Conversion 6,576,400
908 Devices Inc MASS
Series D Preferred Stock · derivative
2020-12-22 Conversion 665,661 $0.00
908 Devices Inc MASS
Series E Preferred Stock · derivative
2020-12-22 Conversion 180,578 $0.00
908 Devices Inc MASS
Series B Preferred Stock · derivative
2020-12-22 Conversion 981,443 $0.00
908 Devices Inc MASS
Common Stock, par value $0.001
2020-12-22 Buy 300,000 $20.00 6,000,000
908 Devices Inc MASS
Common Stock, par value $0.001
2020-12-22 Conversion 5,425,045
908 Devices Inc MASS
Series A Preferred Stock · derivative
2020-12-22 Conversion 2,927,386 $0.00
showing 20 of 109 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com